KZIA - KAZIA THERAPEUTICS LTD

QQQ $ 592.48 $ 0.00 (0 %)

DIA $ 455.78 $ 0.00 (0 %)

SPY $ 653.79 $ 0.00 (0 %)

TLT $ 91.53 $ 0.00 (0 %)

GLD $ 399.78 $ 0.00 (0 %)

Previous Close

$ 6.99

Open

$ 7.18

Bid

$ 6.55 x 80

Ask

$ 6.99 x 53

Day's Range

-- - --

52 Week Range

$ 2.86 - $ 39.05

Volume

37,703

Average Volume

Market Cap

46.53M

Beta (5Y Monthly)

$ 1.13

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
1	11-07-2006	11-06-2006	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Kazia Therapeutics Enters Exclusive Collab...
10/07/2025 12:42:56

Kazia Therapeutics Limited (NASDAQ:KZIA), an oncology-focused drug development company, today announced an exclusive collaborat...

Maxim Group Maintains Buy on Kazia Therape...
10/02/2025 15:15:45

Maxim Group analyst Naz Rahman maintains Kazia Therapeutics (NASDAQ:KZIA) with a Buy and raises the price target from $15 to...

Kazia Therapeutics Reports Reduction In Tu...
10/02/2025 12:36:24

Kazia Therapeutics Limited (NASDAQ:KZIA), an oncology-focused drug development company, today reported a substantial reduction ...

Kazia Therapeutics Announces Its Participa...
10/01/2025 13:23:16

Kazia Therapeutics Limited (NASDAQ:KZIA), a clinical-stage biotechnology company developing innovative therapies for brain canc...

12 Health Care Stocks Moving In Thursday's...
09/11/2025 21:06:02

12 Health Care Stocks Moving In Thursday's...
09/11/2025 12:10:10

Kazia Therapeutics' Paxalisib Shows Comple...
09/11/2025 12:05:33

Kazia Therapeutics Limited (NASDAQ:KZIA), an oncology-focused drug development company, today announced new findings from a col...

12 Health Care Stocks Moving In Friday's P...
08/01/2025 12:07:59

Kazia Therapeutics Announces $2M Private P...
08/01/2025 12:07:56

HC Wainwright & Co. Maintains Buy on Kazia...
07/10/2025 10:35:48

HC Wainwright & Co. analyst Sean Lee maintains Kazia Therapeutics (NASDAQ:KZIA) with a Buy and raises the price target f...

kazia-reports-over-50-cancer-cell-reduction-in-early-data-from-breast-cancer-trial-stock-jumps

Kazia Reports Over 50% Cancer Cell Reducti...
07/09/2025 18:47:12

Kazia's early trial data show significant CTC and cluster reduction in a breast cancer patient treated with Paxalisib, Keyt...

12 Health Care Stocks Moving In Wednesday'...
07/09/2025 17:06:52

12 Health Care Stocks Moving In Wednesday'...
07/09/2025 12:07:32

Kazia Therapeutics Announces Preliminary R...
07/09/2025 12:03:01

Kazia Therapeutics (NASDAQ:KZIA) is pleased to announce preliminary results from the first patient in its Phase 1b trial evalua...

12 Health Care Stocks Moving In Tuesday's ...
07/08/2025 12:07:32

Maxim Group Maintains Buy on Kazia Therape...
06/11/2025 17:32:36

Maxim Group analyst Jason McCarthy maintains Kazia Therapeutics (NASDAQ:KZIA) with a Buy and maintains $15 price target.

kazia-therapeutics-kzia-stock-surges-77-on-positive-preclinical-data-for-breast-cancer-drug

Kazia Therapeutics (KZIA) Stock Surges 77%...
06/11/2025 17:07:09

Kazia on Wednesday announced positive preclinical data for its paxalisib drug in triple-negative breast cancer. The company'...

12 Health Care Stocks Moving In Wednesday'...
06/11/2025 17:06:34

Kazia Therapeutics Shares Halted On Circui...
06/11/2025 14:53:08

12 Health Care Stocks Moving In Wednesday'...
06/11/2025 12:07:40